Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Authors
Keywords
-
Journal
Viruses-Basel
Volume 14, Issue 2, Pages 187
Publisher
MDPI AG
Online
2022-01-20
DOI
10.3390/v14020187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
- (2022) Kah-Whye Peng et al. VACCINE
- Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
- (2021) Dongyan Zhou et al. Cell Host & Microbe
- Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study
- (2021) Gerco den Hartog et al. CLINICAL INFECTIOUS DISEASES
- Intranasal Administration of a Recombinant RBD Vaccine Induced Protective Immunity Against SARS-CoV-2 in Mouse
- (2021) Yingying Du et al. VACCINE
- Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
- (2021) Young-Il Kim et al. mBio
- Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2
- (2021) Romain Gasser et al. Cell Reports
- COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
- (2021) Muhammad Umer Ashraf et al. Vaccines
- Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
- (2021) Shaswath S. Chandrasekar et al. Vaccines
- Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study
- (2021) Kathryn J. Gray et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19.
- (2021) Rick Heida et al. Expert Review of Vaccines
- Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines?
- (2021) Mattia Tiboni et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
- (2021) Yongjun Sui et al. JCI Insight
- Delivery Routes for COVID-19 Vaccines
- (2021) Jang Hyun Park et al. Vaccines
- The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
- (2021) Daniel P. Oran et al. ANNALS OF INTERNAL MEDICINE
- Estimating vaccine efficacy against transmission via effect on viral load
- (2021) Lee Kennedy-Shaffer et al. EPIDEMIOLOGY
- SARS-CoV-2 Antibodies Detected in Mother’s Milk Post-Vaccination
- (2021) Jill K. Baird et al. JOURNAL OF HUMAN LACTATION
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Human IgG and IgA responses to COVID-19 mRNA vaccines
- (2021) Adam V. Wisnewski et al. PLoS One
- Are We Forgetting About IgA? A Re‐examination of Coronavirus Disease 2019 Convalescent Plasma
- (2021) Hans Verkerke et al. TRANSFUSION
- Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
- (2021) Sandro Halwe et al. Viruses-Basel
- An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
- (2021) Ahmed O. Hassan et al. Cell Reports
- SYMPTOMATIC SARS-CoV-2 INFECTIONS AFTER FULL SCHEDULE BNT162b2 VACCINATION IN SEROPOSITIVE HEALTHCARE WORKERS: A CASE SERIES FROM A SINGLE INSTITUTION
- (2021) Andreina Baj et al. Emerging Microbes & Infections
- Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
- (2021) R. Glenn King et al. Vaccines
- Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing
- (2021) Federica Novazzi et al. ANNALS OF INTERNAL MEDICINE
- Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
- (2021) Daniele Focosi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
- (2021) Jingyou Yu et al. JOURNAL OF VIROLOGY
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- (2021) Anika Singanayagam et al. LANCET INFECTIOUS DISEASES
- Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva
- (2021) Keiichi Tsukinoki et al. PLoS One
- Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
- (2021) Dennis Lapuente et al. Nature Communications
- BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women
- (2021) Michal Rosenberg-Friedman et al. Nature Communications
- The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
- (2021) Renee W. Y. Chan et al. Frontiers in Immunology
- Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
- (2021) Peter Bergman et al. EBioMedicine
- Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
- (2021) Eva Piano Mortari et al. Cells
- Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence
- (2020) Richard I. Bailey et al. PLOS BIOLOGY
- The Importance Of Naturally Attenuated Sars‐Cov ‐2 In The Fight Against Covid ‐19
- (2020) Jean Armengaud et al. ENVIRONMENTAL MICROBIOLOGY
- Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
- (2020) Leticia Moreno-Fierros et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response
- (2020) Natalie D. Collins et al. Vaccines
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk
- (2020) Veronique Demers-Mathieu et al. Journal of Perinatology
- A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
- (2020) Shipo Wu et al. Nature Communications
- Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
- (2020) Rajat Mudgal et al. Human Vaccines & Immunotherapeutics
- Robust and specific secretory IgA against SARS-CoV-2 detected in human milk
- (2020) Alisa Fox et al. iScience
- Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
- (2020) Min-Wen Ku et al. Cell Host & Microbe
- Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
- (2020) Jéromine Klingler et al. JOURNAL OF INFECTIOUS DISEASES
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission
- (2020) Benjamin S. Bleier et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
- (2020) Carlo Cervia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Virulence-driven trade-offs in disease transmission: A meta-analysis
- (2019) Miguel A. Acevedo et al. EVOLUTION
- Benefits and Costs of Animal Virulence for Microbes
- (2019) Arturo Casadevall et al. mBio
- A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
- (2019) Li et al. Viruses-Basel
- The rotavirus vaccine development pipeline
- (2017) Carl D. Kirkwood et al. VACCINE
- Neutrophil swarming and extracellular trap formation play a significant role in Alum adjuvant activity
- (2017) J. Stephen et al. npj Vaccines
- Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
- (2016) Jincun Zhao et al. IMMUNITY
- Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits
- (2016) Azhar Choudhry et al. VACCINE
- Current prospects and future challenges for nasal vaccine delivery
- (2016) Helmy Yusuf et al. Human Vaccines & Immunotherapeutics
- A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
- (2016) François Blanquart et al. eLife
- Polio vaccination: past, present and future
- (2015) Ananda S Bandyopadhyay et al. Future Microbiology
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens
- (2015) Andrew F. Read et al. PLOS BIOLOGY
- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
- (2014) L. Du et al. JOURNAL OF IMMUNOLOGY
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits
- (2013) Robert A. Kuschner et al. VACCINE
- Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
- (2012) Dharmendra Raghuwanshi et al. MOLECULAR PHARMACEUTICS
- A new look at an old virus: patterns of mutation accumulation in the human H1N1 influenza virus since 1918
- (2012) Robert W Carter et al. Theoretical Biology and Medical Modelling
- Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
- (2012) Byoung-Shik Shim et al. Virology Journal
- Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
- (2011) Byoung-Shik Shim et al. BMC IMMUNOLOGY
- Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)
- (2011) Natalie J. Carter et al. DRUGS
- Pandemic (H1N1) 2009 virus revisited: An evolutionary retrospective
- (2011) Mary C. Christman et al. INFECTION GENETICS AND EVOLUTION
- PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV
- (2011) Wei-wei Gai et al. VIROLOGICA SINICA
- Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?
- (2010) Peter J. Watts et al. DRUG DISCOVERY TODAY
- Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
- (2010) Baojing Lu et al. IMMUNOLOGY
- Natural attenuation of dengue virus type-2 after a series of island outbreaks: A retrospective phylogenetic study of events in the South Pacific three decades ago
- (2010) Argon Steel et al. VIROLOGY
- A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
- (2009) Xiaoxing Huang et al. PLoS One
- A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults
- (2008) Arthur Lyons et al. VACCINE
- A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
- (2008) Kai Schulze et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started